British biotech firm expanding here
77084
Protherics is a British pharmaceutical company with operations in Wales and Australia, but it has always spoken with an American accent.
731230
The biotech mines extra value from its compound library.
93007
Kristen Galfetti&#39;s small glass office at the new headquarters of Genzyme, a producer of therapeutic drugs in Cambridge, Massachusetts, has two doors.
10738
A partnership deal has investors in the small specialty pharma excited.
680322
The chemical company is looking to grow all over the world.
247030
A British biotechnology company has developed a long-lasting artificial skin that has produced promising results in healing wounds in early clinical trials.
649836
Myriad Genetics' innovative technology creates an investment opportunity.
725261
There's encouraging news about an enzyme replacement drug.
567272
The company teams up with AstraZeneca to bring its antibiotic to worldwide markets.
260929
The med-tech firm impresses on many levels.
375255
Serono is teaming up with California-based biotech firm CancerVax Corp. to develop a new skin cancer drug, as Europe's biggest biotech firm aims to strengthen its pipeline by moving into cancer treatment.
94220
While bigger competitors stumble over each other, Bio-Reference keeps growing.
452269
Engineering firm AK Pharmaceuticals is to open a new Engineering Centre of Excellence in Ireland, in a move that reaffirms the healthy position of the Irish pharmaceutical industry.
761565
A joint biotechnology research venture by two Dutch companies is further underscoring the appeal of the Boston life-science cluster to out-of-state firms, and creating an even tighter real estate market in Cambridge's Kendall Square.
660677
A centre in Edinburgh is to develop human stem cell lines to be sold for woldwide research.
648390
CHESTERFORD RESEARCH PARK, U.K. and STOCKHOLM, Sweden, Sept. 22, 2004 (PRIMEZONE) -- BioFocus plc (AIM:BIO), a world leader in drug discovery, and Biovitrum today announce that Biovitrum has acquired from ...
466497
Adnexus Therapeutics Inc., an ambitious young biotech company in Waltham, says it is going public.